InventisBio Co., Limited (SHA:688382)
China · Delayed Price · Currency is CNY 22.67
+0.19 (0.85%)
At close: May 12, 2026
InventisBio Market Cap
InventisBio has a market cap or net worth of 13 billion as of May 12, 2026. Its market cap has increased by 31.08% in one year.
Market Cap
13.00B
Enterprise Value
11.64B
Revenue
71.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.67
Market Cap Chart
Since July 25, 2022, InventisBio's market cap has increased from 8.79B to 13.00B, an increase of 47.88%. That is a compound annual growth rate of 10.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 13.00B | -17.47% |
| Dec 31, 2025 | 15.75B | 105.38% |
| Dec 31, 2024 | 7.67B | -11.89% |
| Dec 29, 2023 | 8.71B | 14.01% |
| Dec 30, 2022 | 7.64B | -13.15% |
| Jul 25, 2022 | 8.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 14.83B |
| Anhui Anke Biotechnology (Group) | 14.77B |
| Chengdu Olymvax Biopharmaceuticals | 14.61B |
| Staidson (Beijing) BioPharmaceuticals | 13.85B |
| Chengzhi | 13.68B |
| Tibet Cheezheng Tibetan Medicine | 13.01B |
| Hualan Biological Vaccine | 12.61B |
| Chongqing Genrix Biopharmaceutical | 11.39B |